Due to its essential yet toxic nature in biological systems (1) (2) (3) , the intracellular concentration of copper ions is tightly controlled in the yeast Saccharomyces cerevisiae, in part, by regulating the expression of the genes CTR1 and CTR3 that encode copper ion transporters at both transcriptional and posttranslational levels (4 -10) . The CTR1 and CTR3 transcription is enhanced by copper starvation (addition of chelator bathocuproinedisulfonate (BCS) 1 in the growth medium) and inactivated by even a slight increase in the copper ion concentrations (of picomolar range) (9) . The transporter Ctr1p is induced to undergo degradation by toxic copper levels (of 10 M or higher), which is thought to further inhibit copper uptake under toxic conditions (6) . Interestingly, a recent study (33) reports that the Ctr3p, unlike the Ctr1p, does not undergo degradation in response to toxic copper levels. This latest finding may explain the earlier report that CTR3 is disrupted by a transposon element in most yeast laboratory strains (5) . These concentration-dependent responses noted above indicate that cells are able to sense and differentiate the physiological from toxic levels of copper ions. How the degradation of Ctr1p is controlled is currently unknown. The transcription of CTR1 and CTR3 is regulated by the copper-sensing factor Mac1p through the cis-acting CuREs in the promoters (9) . However, how the copper ion signal, particularly that of physiological and toxic levels, is propagated to the promoters of CTR1 and CTR3 is currently poorly understood.
The primary sequence indicates that the Mac1p may sense copper ions through direct copper ion coordination (7) , similar to the two other known copper-sensing factors Ace1p and Amt1p (11) (12) (13) (14) . Biochemical studies show that the separated DNA-binding domain and the activation domain of Mac1p expressed in the Escherichia coli both bind Cu ϩ ions (15) . The bacteria-expressed DNA-binding domain was also found to coordinate Zn 2ϩ ; a zinc-module was then postulated to also exist in the Mac1p DNA-binding domain (15) . The DNA-binding domain of Amt1p expressed in the bacteria was the first copper-sensing factor found to be Zn 2ϩ -coordinated (16) . However, this Zn 2ϩ coordination was not required for the Amt1p to bind DNA (16) . DNA binding activities at the CuREs in the promoters of CTR1 and CTR3 have been detected in the yeast extracts prepared from the cells expressing various forms of the truncated Mac1 protein (17) . The purified truncate of Mac1p(1-159), which lacks the activation domain, was also found able to bind the CuREs (15) . In vitro translated Mac1p has also been shown to be able to bind the CTR1 promoter (8) . These studies have demonstrated that Mac1p is able to bind the CuREs. However, whether or not copper affects Mac1p DNA binding has yet to be resolved. In vivo footprinting showed that upon CuSO 4 treatment, the CuREs in the CTR3 promoter became more accessible to the methylation reagent (9), indicative of possible dissociation of Mac1p. The DNA binding activities of the yeast extracts, prepared from the cells expressing the truncated Mac1p and grown in the medium containing either BCS or CuSO 4 , exhibited no difference (15) . There is no report on the copper effect on Mac1p DNA binding by the addition of CuSO 4 to the binding reactions using yeast cell extracts or purified proteins.
The previous study using Mac1 fusion proteins with Gal4p (either DNA-binding or activation domain) and VP16 provided indirect evidence that there are interactions between the DNAbinding and activation domain of the Mac1p (17) . It is postulated that copper-induced intramolecular interactions inhibit both DNA binding and transactivation activities of the Mac1p (17, 18) . A more recent study using one-and two-hybrid methods also suggests that the intramolecular interaction negatively modulates Mac1p activity (19) .
In this report, we describe the finding that the Mac1p undergoes posttranslational phosphorylation and that the phosphorylation is required for the Mac1p to bind to the CuRE in the CTR1 promoter. The dephosphorylated Mac1p is unable to bind the DNA. We also found that the Mac1p DNA binding, on one hand, is dependent on Cu ϩ coordination and, on the other hand, is disrupted by the addition of copper ions. These studies indicate that Mac1p is able to sense two different copper levels and that the posttranslational phosphorylation of Mac1p is probably a key event in the regulation of copper transport.
EXPERIMENTAL PROCEDURES
Plasmid Construction, Cell Growth, and Protein Analysis-A high copy plasmid pGPD-Mac1HA(opt) was constructed by cloning a BamHIXhoI fragment of an artificial MAC1 into the p423GPD vector at the same sites (20) . The artificial MAC1 has optimal codons and is tagged with a single copy of HA epitope at the carboxyl terminus. The DNA was synthesized in vitro (GeneMed).
A single copy plasmid pRSMac1(3HA) was constructed essentially the same as pRSMac1(HA) as described previously (10) . To introduce 3 ϫ HA epitopes in the MAC1 coding region, a NarI site was generated by silent mutations at the DNA encoding residues Gly-222 and Ala-223. Complementary oligonucleotides were synthesized for a DNA fragment encoding three copies of the nine amino acids of the HA epitope with flanking NarI sites. The oligonucleotides were annealed and cloned into the NarI site of the MAC1.
Plasmids were transformed into the SLY2(mac1⌬) cells as described previously (10) . The cells were grown in the copper ion-depleted medium treated with Chelex (Bio-Rad) (6) . Yeast whole cell extracts were prepared using the previously described method (6) or by using the glass bead disruption method (21) . The protein concentrations of the extracts were determined using the Bradford protein assay (21) . The lysis buffer contained 20 mM Tris-HCl, pH 7.4, 10 mM MgCl 2 , 5 mM dithiothreitol. The protein extracts were treated with -protein phosphatase (New England Biolabs). After the treatment, proteins were precipitated using trichloroacetic acid, fractionated on 8.5% SDS-polyacrylamide gels, and then transferred to a nitrocellulose membrane as described previously (21) . Western blotting analyses were then carried out using a polyclonal anti-HA antibody, Y11 (Santa Cruz Biotechnology Inc.) (10) .
In vivo 32 P-Labeling and Immunoprecipitation-SLY2 cells transformed with pRSMac1(3HA) or control plasmid pRS313 were used to carry out in vivo 32 P-labeling (22) . Cells were pre-grown overnight in the copper-depleted selective medium synthetic complete medium lacking histidine without phosphate and reinoculated into 5 ml of synthetic complete medium lacking histidine medium of 0.02 of the normal phosphate level with a starting OD 650 of 0.4.
32 P-Inorganic phosphate (ICN) was added to a final concentration of 200 Ci/ml. Cells were grown until the OD 650 reached ϳ1.5 and then harvested. Cell pellets were washed with H 2 O, and whole cell extracts were prepared using the method described previously (6) . The proteins were dissolved in buffer A (50 mM Na 3 PO 4 , pH 7.0, 25 mM MES, pH 7.0, 1% SDS, 3 M urea, 0.5% ␤-mercaptoethanol, 50 mM NaF). Protein concentrations in the extracts were measured as described above. For immunoprecipitation, 250 g of total proteins in 100 l of buffer A was mixed with 700 l of buffer B (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5% Tween 20, 0.1 mM EDTA), and 5 l of anti-HA antibody 12CA5 was added. The reactions were incubated on a rotating wheel for 2 h at 4°C. Protein A-Sepharose CL-4B beads were added with 10 l of 100 mM bovine serum albumin, and the reactions were incubated overnight at 4°C on a rotating wheel. Immunocomplexes were precipitated by microcentrifuge at 13,000 rpm and washed five times with the buffer B. The complexes were eluted in 40 l of SDS-polyacrylamide gel electrophoresis sample buffer by heating at 80°C for 10 min. Twenty microliters of elutes were analyzed on a 6% SDS-polyacrylamide gel. The gel was fixed and dried and exposed to Kodak Biomax film at Ϫ80°C with an intensifying screen. The exposure time that was required for autoradiographic detection of Mac1p phosphorylation was 2-4 days.
DNA Binding Experiments-Yeast extracts were prepared from cells of SLY2 harboring pGPD-Mac1HA(opt) or vector p423GPD grown in copper-depleted medium, using the glass bead disruption method (21), in lysis buffer of 20 mM Tris-HCl, pH 7.4, 100 mM NaCl, 5 mM ␤-mercaptoethanol, 10% glycerol.
32 P-Labeled CTR1 promoter DNA fragment was generated by polymerase chain reactions using [ 32 P]dATP. The primers used for the wild type DNA were 5Ј-CATGTATTGATGCAA-3Ј and 5Ј-CTTGAAAAGTGCTC-3Ј, and primers used for the mutant probe were 5Ј-CATGTATTGATGCAAATCATGGGATAGGGATGAAAGACG-ACGGTAAAA-3Ј and 5Ј-CTTGAAAAGTGCTCTTTTCAGGATCGTGC-CATTGGGATGAATTTTACCGTC-3Ј. The radioactive DNAs were purified by the agarose gel electrophoresis. Because of the observed interference of the Mn 2ϩ on Mac1p DNA binding, calf intestinal phosphatase (New England Biolabs) was used to dephosphorylate the Mac1p in the protein extracts. The phosphatase inhibitors, glycerol phosphate (40 mM), NaF (50 mM), and okadeic acid (2 M), were used as previously described (24) . The binding reactions were carried out as described previously (23) .
RESULTS

Mac1p Undergoes Posttranslational Phosphorylation in S.
cerevisiae-Probably because of the low physiological level of Mac1p in the yeast cells, our repeated efforts to detect the CuRE binding activity of Mac1p in the yeast extracts did not produce conclusive results. An artificial MAC1 of optimized codons, tagged with a single copy of HA epitope at the carboxyl terminus, was then synthesized in vitro, and the Mac1-HA protein was expressed in the SLY2 cells carrying the synthetic gene on a high copy plasmid pGPG-Mac1HA(opt) as described under "Experimental Procedures." As shown in Fig. 1A , three proteins (two labeled with p-Mac1-HA and one with Mac1-HA) were detected by immunoblotting using polyclonal anti-HA antibody Y11 and found only in cells harboring the plasmid pGPD-Mac1HA(opt). Compared with the E. coli-expressed Mac1-HA, the two proteins had higher molecular masses. Upon protein phosphatase treatment, the two proteins collapsed to the protein Mac-HAp, which migrated at 57 kDa. The E. coliexpressed Mac1-HA also migrated at 57 kDa. Protein phosphatase treatment did not change the E. coli-expressed Mac1-HA (data not shown). This result indicates that the Mac1-HAp when overexpressed undergoes phosphorylation modification in the yeast cells but not in the bacteria.
We observed that the overexpression causes hyperphosphorylation of the Mac1-HA protein (data not shown). In SLY2 cells transformed with the single copy plasmid pRSMac1(HA) (10), the level of the phosphorylated Mac1-HAp was found to be very low and hardly detectable (Fig. 1B) . To enhance immunological detection, the plasmid pRSMac1(3HA) was constructed as described under "Experimental Procedures" in which three copies of the HA epitope were inserted in Mac1p between the Gly-222 and Ala-223 residues. The Mac1-3HAp was functional in the activation of CTR1 and CTR3 transcription, judging from the growth on nonfermentable carbon source yeast medium containing the non-fermentable carbon source ethanol plate (Fig. 1D) . As shown in Fig. 1B , in SLY2 cells harboring pRSMac1(3HA) plasmid, two specific protein bands were detected with one band significantly more abundant than the other, corresponding to nonphosphorylated and phosphorylated Mac1-3HAp, respectively. We then carried out metabolic labeling with 32 P-inorganic phosphate and subsequent immunoprecipitation. In Fig. 1C, a 32 P-radioactive protein of the Mac1-3HAp molecular weight was detected from 32 P metabolically labeled cells expressing Mac1-3HAp but not from the 32 P-labeled control cells. These results together have demonstrated that phosphorylation of Mac1p also occurs at a physiological level.
The Exogenous Copper Ions Disrupt the DNA Binding of Mac1p-Based on the findings described above, we speculate that our prior failure to detect the DNA binding activity of Mac1p in the yeast extracts is possibly due to the observed very low abundance of the phosphorylated Mac1p. We then conducted electrophoretic mobility shift assays to determine whether or not the Mac1p DNA binding was affected by copper ions. To conduct this experiment, we used yeast whole cell extracts, prepared from the SLY2 containing the pGPDMac1HA(opt) plasmid and 32 P-labeled wild type CTR1 promoter DNA fragment, and a mutant fragment in which both CuREs are mutated (9) . The yeast cells were grown in copperdeficient medium, and extracts were prepared as described above. As shown in Fig. 2 , a shifted complex was detected in the reactions between 32 P-labeled wild type CTR1 promoter DNA and the extract prepared from cells expressing Mac1-HA (lanes 3 and 4) but not from control cells (lane 2). The addition of CuSO 4 at both 1 M and 100 M concentrations (lane 5 and 6) disrupted the complex. In the reaction containing the mutant CTR1 promoter DNA, no such complex was detected (lane 7), confirming previous genetic analysis and in vivo footprinting that the CuREs serve as the copper-responsive elements in the CTR1 and CTR3 promoters (9) . Inclusion of the anti-HA antibody in the reaction (lane 10) caused a supershift of the complex, indicating that Mac1-HAp is present in the complex. Competition reactions (lanes 8 and 9) show that Mac1-HA formed a specific complex with the wild type CTR1 promoter DNA. Our data then demonstrate that the Mac1p DNA binding is copper ion-responsive, suggesting that the copper ion-triggered disruption of Mac1p DNA binding probably results in the transcriptional inactivation of CTR1 and CTR3.
The Phosphorylation and Cu ϩ Coordination of Mac1p Are Required to Bind the CuRE in the CTR1 Promoter-We next characterized the effect of Mac1p phosphorylation on its DNA binding by performing the electrophoretic mobility shift assays using the same yeast extracts, both treated and not treated with protein phosphatase (as shown in Fig. 3) . Consistent with the data in Fig. 2 , the Mac1-HAp-containing complex was detected ( lanes 3 and 4) , and the complex was disrupted by copper (lanes 5 and 6) and by the isoelectronic Ag ϩ as well (lane 7). Ag ϩ represses the CTR1 and CTR3 transcription in a manner indistinguishable to Cu ϩ (9). These data further substantiate our finding that Mac1p DNA binding is copper ion-responsive. Also shown in the Fig. 3 , the addition of BCS (lane 8), the Cu ϩ -specific chelator, disrupted the complex, but EDTA (lane 9), a mainly divalent metal ion chelator, had no effect. These results indicate that the Mac1p DNA binding is also Cu ϩ coordination-dependent, much like the Ace1p and Amt1p, suggesting that the DNA-binding active Mac1p is likely to be Cu ϩ -bound even under copper-limiting conditions. In lane 10, the phosphatase treatment almost completely abolished the DNA binding activity of the Mac1-HAp in the extract sample showing that the phosphorylation of Mac1p is required to bind the CTR1 promoter. Interestingly, the addition of the phosphatase inhibitors (lane 11) did not prevent copper ions from disrupting Mac1-HA DNA binding in vitro, implying that copper disrupts the DNA binding of Mac1p probably through a mechanism SLY2 cells harboring pRSMac1(3HA) or pRSMac1(HA) or control vector pRS313 plasmid were grown in copper-depleted medium. Yeast whole cell extracts were prepared, and Mac1-HAp and Mac1-3HA were detected by immunoblotting as described above. C, in vivo 32 P-labeling and immunoprecipitation of Mac1p. SLY2 cells transformed with pRSMac1(3HA) or control plasmid pRS313 were grown in copper-depleted medium in the presence of 32 P-inorganic phosphate, and whole cell protein extracts were prepared as described under "Experimental Procedures." Immunoprecipitation was carried out with anti-HA antibody 12CA5 and protein A-Sepharose beads. Immunocomplexes were analyzed on an 8.5% SDS-polyacrylamide gel. D, Mac1-3HA is functional in the activation of CTR1 and CTR3 transcription. Transformants of SLY2 with the vector pRS313 (mac1⌬), pRSMac1(HA) (MAC1-HA), or pRSMac1(3HA) (MAC1-HA) were streaked onto yeast medium containing a nonfermentable carbon source (YPE). Cells were incubated for 48 h and photographed. other than dephosphorylation. These results together show that the two, phosphorylation and Cu ϩ coordination, are both required for the Mac1p to bind the CuREs in the promoters of CTR1 and CTR3.
DISCUSSION
In this report, we have demonstrated that Mac1p undergoes phosphorylation modification in yeast cells but not in bacteria and that the phosphorylation is required for Mac1p to bind to its target gene, the CTR1 promoter (and presumably the CTR3 promoter as well). The nonphosphorylated Mac1p failed to bind DNA at all. A previous report, however, has shown that the separated DNA-binding domain is able to bind the CTR1 promoter (15) . Our lab has also found that the purified DNAbinding domain of Mac1p is able to bind CTR1 promoter eventhough the DNA-binding domain protein is not phosphorylated (data not shown). Taken together, these findings suggest that the activity of the DNA-binding domain is inhibited in the nonphosphorylated Mac1p and that the inhibition is abolished upon phosphorylation of Mac1p. Consistent with this notion, two earlier studies (17, 18) have reported that there are probably intermolecular interactions between the DNA-binding and activation domains of Mac1p and that the activation domain negatively may regulate the activity of the DNA-binding domain (19) . Therefore, in Mac1p, the activation domain regulates the activity of the DNA-binding domain possibly in a phosphorylation-dependent fashion. Supporting this mechanism, our preliminary studies indicate that the phosphorylation occurs within the activation domain of Mac1p, not in the DNA-binding domain. 2 The activation domain of Mac1p clearly plays an active role in the regulation of CTR1 and CTR3 transcription in response to changes in copper ion concentrations. The phosphorylation of proteins is a general mechanism for cells to respond to extracellular signaling (25) . This report indicates that regulation of copper ion uptake most likely involves a phosphorylation-based signal transduction mechanism. A recent study (26) has also indicated that Aft1p, the iron-sensing factor, undergoes possible phosphorylation modification. Therefore, the phosphorylation modification may represent a new yet common mechanism by which cells sense metal ions.
Our finding that copper ions affect the DNA binding of Mac1p represents important progress in the understanding of the mechanism by which Mac1p functions in the regulation of CTR1 and CTR3 transcription. The sequence homology among Mac1p, Ace1p, and Amt1p within their NH 2 -terminal DNAbinding domain suggests that these factors may function similarly in sensing copper ions (7) . A recent study (27) has reported that Cuf1, a critical factor in the regulation of copper and iron uptake in Schizosaccharomyces pombe, also shares this homology. It is a known fact that for the Ace1p and Amt1p to activate the transcription of MT genes, both proteins have to bind copper ions first and then become DNA-binding active (28, 29) . This mechanism is clearly suited to assure that this detoxifying response is only activated in cells exposed to toxic levels of copper ions, not under physiological conditions because MTs inhibit the copper acquisition by other copper-dependent enzymes, such as Cu,Zn-SOD (30) . Therefore, the Ace1p and Amt1p are sensors for the toxic level of copper ions. Our studies haveshownthattheMac1pDNAbindingisalsoCu ϩ coordinationdependent, eventhough the deficiency of copper ions triggers the Mac1p to activate the transcription of CTR1 and CTR3. Equally important, we have also demonstrated that the exogenous copper ion and isoelectronic Ag ϩ disrupt the Cu ϩ coordination-dependent DNA binding of Mac1p. Our results are seemingly contradictory, yet they unmistakably indicate that the Mac1p is able to sense two different copper levels, reflecting the very nature of copper in living organisms, essential yet toxic depending on its concentrations. We speculate that the dependence of Mac1p DNA binding on Cu ϩ coordination probably represents the ability of Mac1p to sense the physiological copper level, whereas the copper disruption of Mac1p DNA binding may exemplify its ability to sense the toxic level of copper ions. Mac1p contains two clustered metal ion binding motifs of typical CXC and CXXC nature located within the DNA-binding and the activation domains, respectively (7). The DNA-binding and the activation domains are the possible structural basis for the sensing of the two copper levels by Mac1p. An important question is how Mac1p can detect these two different copper levels? And equally important, under the copper-limiting condition, why is the Mac1p able to bind copper ions and activate the CTR1 and CTR3 transcription but not the Ace1p, eventhough Mac1p and Ace1p share an almost identical Cu ϩ binding motif within their DNA-binding domains? One plausible model is that the copper ion binding motifs within the DNA-binding and activation domains of Mac1p may have different affinities to copper ions and that Mac1p DNA-binding domain has much higher affinity to copper ions than does the Ace1p DNA-binding domain. Biochemical studies currently underway in our laboratory will shed light on this possible mechanism.
The transcription of CTR1 and CTR3 has been shown previ-2 Z. Zhu, M. Crooks, M. Depaz, and J. Heredia, manuscript in preparation.
FIG. 3. Phosphorylation and Cu
؉ coordination of Mac1p are required for binding CTR1 promoter DNA. Electrophoretic mobility shift assays using 32 P-labeled CTR1 promoter fragments and phosphatase-treated protein extracts are shown. The same whole cell extracts were used, and the reactions were carried out as described in the ously to be extremely sensitive to increases in exogenous copper ion (9) . Our data have provided a framework for understanding how Mac1p may activate the transcription under copper-limiting conditions. However, the mechanism by which the increase in copper ion concentrations triggers the inactivation of CTR1 and CTR3 transcription is still poorly understood. We have reported here that copper triggers the repression of CTR1 and CTR3 transcription possibly by disrupting the DNAbinding of Mac1p. Because the phosphatase inhibitors did not prevent copper from disrupting Mac1p-binding DNA (Fig. 3) , this suggests that copper disrupts Mac1p DNA binding potentially by a means other than triggering dephosphorylation of Mac1p (10) . 2 The new features of how Mac1p functions as reported in this work, particularly the ability to sense the two different levels of copper ions, are consistent with its regulatory role in copper ion transport. Further studies are warranted to determine the precise molecular mechanism by which cells differentiate the physiological from toxic levels of copper ions. This is particularly true because Menkes' and Wilson diseases are caused by copper ion deficiency and excess copper ion toxicity, respectively (for review see Refs. 31 and 32).
